Insider · CIK 0002041855
Gregory D Davis
officer
Files at SGMOQ (SANGAMO THERAPEUTICS, INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -832 | $0.47 | $393 | 190,230 | Feb 26, 2026 |
| Feb 25, 2026 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -5,119 | $0.47 | $2,406 | 185,111 | Feb 26, 2026 |
| Jan 22, 2026 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -7,721 | $0.40 | $3,077 | 191,062 | Jan 26, 2026 |
| Nov 24, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -723 | $0.42 | $301 | 193,791 | Nov 26, 2025 |
| Oct 22, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -6,708 | $0.66 | $4,427 | 194,514 | Oct 24, 2025 |
| Aug 24, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -723 | $0.59 | $424 | 201,222 | Aug 26, 2025 |
| Jul 22, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -6,708 | $0.48 | $3,219 | 201,945 | Jul 24, 2025 |
| May 24, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -723 | $0.47 | $342 | 208,653 | May 28, 2025 |
| Apr 22, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -6,708 | $0.78 | $5,207 | 209,376 | Apr 24, 2025 |
| Feb 24, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -705 | $1.00 | $705 | 166,865 | Feb 26, 2025 |
| Feb 25, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -507 | $0.96 | $485 | 166,358 | Feb 26, 2025 |
| Feb 25, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | AGrant or award Common Stock | +49,726 | $0.00 | $0 | 216,084 | Feb 26, 2025 |
| Feb 25, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | AGrant or award Stock Option (Right to Buy)derivative | +99,454 | $0.00 | $0 | 99,454 | Feb 26, 2025 |
| Jan 22, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -30,456 | $1.15 | $35k | 167,570 | Jan 24, 2025 |
| Nov 24, 2024 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -721 | $1.88 | $1,355 | 202,368 | Nov 26, 2024 |
| Nov 25, 2024 | SGMOQ SANGAMO THERAPEUTICS, INC | FTax withholding Common Stock | -505 | $1.94 | $980 | 201,863 | Nov 26, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.